Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on May 10, 2023 8:29am
Share count ...
Can anyone recall the peak of GUD's share count? Was it around 130 MM shares ?
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on May 10, 2023 8:11am
RE:April Buybacks: Roughly 900K Shares
And a few more on top of that. Below 100M shares fairly quickly - IMO. Filed 2023-05-09 12:46 Tx date 2023-04-30 $GUD Knight Therapeutics
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on May 09, 2023 5:30pm
RE:A few things to note, upcoming!
Maybe the shorts will get squeezed a little this time. 3% of the stock is short. There is also a new item on Sedar for those who care it's in French. The interest in the stock should start picking
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on May 09, 2023 3:54pm
National post article
Showing how Opiod crisis actuall getting larger. from today May 9! - 'Safer Supply' FUELLING OPIOID CRISIS
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on May 09, 2023 1:12pm
& continued share buybacks
Pretty interesting... -less shares, continuing profits... -increased tailwinds
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on May 09, 2023 1:10pm
A few things to note, upcoming!
1) the earnings release on Thursday 2) samira in NYC next Tuesday
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 09, 2023 1:01pm
New Press Release - Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City
MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2023 RBC...
read article.
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on May 09, 2023 12:45pm
April Buybacks: Roughly 900K Shares
The buybacks continued in April. It's incredible how little interest there is for this stock -- the buybacks account for a substantial portion of the daily trading volume.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on May 06, 2023 3:53pm
RE:Eternal Groundhog Day
Pitchin ... You do realize a few things. First - I personally don't care if you buy or sell. Not just you ... most people. Second - these kinds of social sites are only good for finding
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on May 05, 2023 2:51pm
RE:RE:Eternal Groundhog Day
As a sidenote, GUD has been buying back shares aggressively and are on pace to maxing out the allotted 8M shares until mid July which would put us at around 107M shares outstanding. 34M of them owned
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on May 05, 2023 1:54pm
RE:Eternal Groundhog Day
This may come as a shocker, but I also think a lot has changed over the last couple of years. The company is completely different than it was pre-covid and since then sales have gone up about 50
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on May 05, 2023 1:15pm
RE:Eternal Groundhog Day
Thanks for posting here. I would love to hear more of your thoughts on why nothing will change and how nothing has changed. The business certainly has changed through the past few years. Do you
...more
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Post by
PitchinPennies
on May 05, 2023 12:00pm
Eternal Groundhog Day
I like to look in on GUD every now and then, just to see if anything has changed. Nothing has changed. My personal view is that stasis will forever be the condition of this company. Ten or twenty
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 04, 2023 7:30am
New Press Release - Notice of Knight Therapeutics' First Quarter 2023 Results Conference Call
MONTREAL, May 04, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2023 financial results on Thursday, May 11, 2023 prior to market opening. Following the release, Knight will...
read article.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet the Top 5 Best Online Brokerages in Canada
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips